Dialysis Nurse - On-site, Porto (Part Time)

Diaverum AB; Porto; Híbrido; EUR 18 000 - 30 000; Tempo parcial

Vantagens oferecidas por esta oferta de emprego

Training in dialysis techniques

Multidisciplinary team integration

Career development opportunities

On-site Boavista clinic in Porto

Resumo da oferta

Diaverum AB in Porto, Boavista clinic, is looking for a Hemodialysis Nurse (m/f) to join the supply of services team on-site. The role involves providing nursing care across the clinic and contributing to high-quality patient care. You will participate in ongoing training in dialysis techniques and work within a multidisciplinary team.

Fluency in Portuguese is required and English is an advantage. This position offers opportunities for professional development and a chance to impact patients'

Qualificações

• Nursing degree and valid professional license.
• Portuguese fluency; English a plus.
• Dialysis experience valued but not required.
• Knowledge of quality management systems a plus.

Responsabilidades

• Provide nursing care across the clinic's settings.
• Ensure quality and safety standards are followed.
• Document nursing interventions promptly.
• Promote patient and family empowerment and adherence.
• Communicate effectively with patients and families.
• Participate in training and professional development.
• Support workload management of the nursing team.

Conhecimentos

Fluency in Portuguese

English language skills

Communication

Teamwork

Initiative

Critical thinking

Formação académica

Nursing degree and license

Descrição da oferta de emprego

Diaverum AB in Porto, Boavista clinic, is looking for a Hemodialysis Nurse (m/f) to join the supply of services team on-site. The role involves providing nursing care across the clinic and contributing to high-quality patient care. You will participate in ongoing training in dialysis techniques and work within a multidisciplinary team.

Fluency in Portuguese is required and English is an advantage. This position offers opportunities for professional development and a chance to impact patients'